argenx

Pharma

J&J data set up Imaavy for expansion to treat anemic disorder

J&J has unveiled data from a trial which could pave the way for a label expansion for Imaavy to become the first therapy for a rare autoimmune disease

Kevin Dunleavy Jun 11, 2026 10:36am

Collage poster study of businessmen picture chart arrow goes up

Orphan drug sales to surge past $400B in 2032: report

Mar 12, 2026 8:20am

Close up shot of the target from a dart game

Argenx's Vyvgart posts ph. 3 win in ocular myasthenia gravis

Feb 26, 2026 11:18am

FDA untitled letters target drug ads from Novo, argenx, Sobi

Feb 10, 2026 11:42am

Argenx telegraphs CEO switch as chief drug Vyvgart rolls ahead

Jan 5, 2026 2:12pm

Argenx cans Vyvgart trials in thyroid eye disease over futility

Dec 15, 2025 10:00am